← All organizations

Prelude Therapeutics

For profitWebsite ↗

Also known as: Prelude Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2024

Timeline

2010s

Jun 1, 2016
Prelude Therapeutics— Founded

Drugs by trial phase (8 distinct, 11 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT06682806Lead sponsorPhase 2Dec 31, 2024
NCT06560645Lead sponsorPhase 1Nov 4, 2024
NCT05665530Lead sponsorPhase 1Mar 31, 2023
NCT05639751Lead sponsorPhase 1Jan 31, 2023
NCT05538572Lead sponsorPhase 1Dec 31, 2022
NCT05159518Lead sponsorPhase 1Dec 31, 2021
NCT05107856Lead sponsorPhase 1Nov 30, 2021
NCT04837677Lead sponsorPhase 1Aug 11, 2021
NCT04543305Lead sponsorPhase 1Sep 28, 2020
NCT04089449Lead sponsorPhase 1Oct 31, 2019
NCT03886831Lead sponsorPhase 1Feb 11, 2019

Details

Founded: Wilmington, DE, US Jun 1, 2016
Last known activity: Dec 31, 2024